Navigation Links
Scientists discover bacteria that can cause bone infections
Date:10/17/2008

cteria."

The new pathogen is closely related to Mycobacterium intracellulare and Mycobacterium avium, which cause a lung disease similar to tuberculosis in people, especially those with weak immune systems such as HIV patients that are immunologically suppressed. It is rod-shaped and grows slowly.

"Mycobacterium arosiense can be killed by several antibiotics in the lab, including clarithromycin and rifamycins. However, resistance to fluoroquinolones and isoniazid was observed," said Dr Bang. "Little knowledge is available on performing resistance tests on mycobacteria other than tuberculosis."

"We hope that this discovery will help doctors to diagnose similar diseases in the future and that further investigation may improve the treatment of people with similar infections."


'/>"/>

Contact: Lucy Goodchild
press@sgm.ac.uk
44-011-898-81843
Society for General Microbiology
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. Scientists propose the creation of a new type of seed bank
2. EMBO honors 59 leading life scientists
3. Caltech scientists engineer supersensitive receptor, gain better understanding of dopamine system
4. Extreme nature helps scientists design nano materials
5. Forsyth scientists trigger cancer-like response from embryonic stem cells
6. Scientists trace molecular origin of proportional development
7. Sensitive nanowire disease detectors made by Yale scientists
8. Scent on demand: Hebrew University scientists enhance the scent of flowers
9. MSU scientists find new gene that helps plants beat the heat
10. Cold Spring Harbor Laboratory scientists trace a novel way cells are disrupted in cancer
11. Brookhaven scientists take off for southeastern Pacific climate study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Dr. Daniel Leskovar, a Texas AgriLife Research plant ... in Uvalde, has been investigating ways to help vegetable ... to the field. , "This research can aid in ... of some vegetable crops by producing high-quality, more adaptive ...
(Date:12/4/2009)... widely used by physicians and scientists to study brain ... remained largely unknown whether the electrodes on the head ... the brain. Scientists at the Max Planck Institute for ... crucial link between the activity generated within the brain ...
(Date:12/3/2009)... 3 BIO-key International, Inc. (OTC Bulletin Board: ... finger-based biometric identification solutions, announced that a majority ... held today approved the sale of the company,s ... Of the shares voted, 98.6% were cast in ...
Breaking Biology News(10 mins):Texas AgriLife researchers helping 2Texas AgriLife researchers helping 3Texas AgriLife researchers helping 4How to read brain activity? 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Council for American Medical Innovation to Host Capitol Hill Breakfast Briefing on Education and Immigration 3A The Building Blocks of Innovation 56116 1Council for American Medical Innovation to Host Capitol Hill Breakfast Briefing on Education and Immigration 3A The Building Blocks of Innovation 56116 2The Power of Five 3A New OmniFlex Nourishes Joints in Convenient Effective Doses 56112 1The Power of Five 3A New OmniFlex Nourishes Joints in Convenient Effective Doses 56112 2Arena Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Global Investment Conference 13817 1Arena Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Global Investment Conference 13817 2Arena Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Global Investment Conference 13817 3
... trees -- some are short and bushy with many branches ... of one or two main trunks. Different branching patterns correlate ... these dissimilar patterns come about and why. , A new ... University of New Jersey, examines the role of the protein ...
... gene expression in the brain can differ significantly among ... study indicates that roughly 15 percent of Atlantic salmon ... their freshwater birthplaces to mature in oceans versus those ... , The researchers, at Harvard University, the University of ...
... biological trigger that gives rise to Van Buchem ... cause blindness and deafness. The findings provide insight ... new treatments for osteoporosis and other crippling bone ... and Lawrence Berkeley national laboratories, the Novartis Institutes ...
Other Biology News:Snapin: A protein with therapy potential for autism 2Divergent life history shapes gene expression in brains of salmon 2Researchers track down cause of a disfiguring bone disorder 2Researchers track down cause of a disfiguring bone disorder 3
(Date:12/2/2009)... NEW YORK, Dec. 2 Reportlinker.com announces ... available in its catalogue: ,, Carbondioxide ... ,, http://www.reportlinker.com/p0164368/Carbondioxide-Incubators---A-Global-Market-Perspective.html ,, Incubators ... microbiology, genetics, cancer, research, and other applications ...
(Date:12/2/2009)... Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ... previously announced unit offering, the underwriters have exercised in ... units. Each unit is comprised of one common share ... was sold at a price of US$3.00 per unit. ...
(Date:12/2/2009)... today announced data presentations on its novel oral JAK2 ... Annual Meeting and Exposition in New Orleans. ,, Data ... Phase 1 dose-escalation trial of SB1518 detailing its safety, ... from 100 to 600 mg. These doses were administered ...
(Date:12/2/2009)... The Scientist, a leading scientific magazine covering the life sciences, ... “Top 10 Innovations of 2009. , ... ... EMCCD camera from Photometrics ®, a designer and ...
Breaking Biology Technology:Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3
... April 23 STAAR Surgical,Company (Nasdaq: STAA ... invasive ophthalmic products, today announced very strong,participation in ... the Company,s,Visian ICL(TM) (Implantable Collamer Lens). The first ... My Website Compels Patients to Call,Me," is part ...
... Pipeline of Oncology Products Including Novel Nucleoside Analogue; New ... ... MacroChem Corporation (OTC,Bulletin Board: MACM) announced today that on April ... company,developing and commercializing novel therapeutics, with a portfolio of,clinical stage ...
... patients treated with PBI-1402 did not require blood ... ... ProMetic Life Sciences Inc.,(TSX: PLI) ("ProMetic") announces that oral PBI-1402 demonstrates,significant ... red blood cell ("RBC") transfusion., Only 2 patients out of ...
Other Biology Technology:More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch 2More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch 3MacroChem Acquires Virium Pharmaceuticals 2MacroChem Acquires Virium Pharmaceuticals 3MacroChem Acquires Virium Pharmaceuticals 4MacroChem Acquires Virium Pharmaceuticals 5Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial 2Oral PBI-1402 Demonstrates Significant Activity in Chemotherapy-Induced Anemia Phase II Clinical Trial 3
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
3M Imidazole Solution 125 ml...
PFM8 Antibody...
Goat polyclonal to DDDDK tag (FITC) ( Abpromise for all tested applications)....
Biology Products: